ARCHIVES

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

This article is from The Cancer Letter archive.

Vol. 38 No. 16 | April 20, 2012

Download PDF Visit The Full Archive

Related Articles

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010

In Brief: Baylor Campus to Build Joint Cancer Center

January 17, 2014

UC Breast Cancer ProgramTo Award $20 Million In Grants

December 16, 1994

NCI says SELECT study is close to full enrollment.

April 23, 2004

Treatment IND or GM-CSF Is Approved

October 5, 1990

Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines

January 13, 2012